Delivery Order SPE2DB22D2009-SPE2DB24FL9UM

Award Date 5/20/24
Potential Completion Date 5/21/24
Potential Value $20K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Jardiance 25 mg tablets. The $12,835.82 firm fixed-price delivery order contract has an ultimate completion date of February 2, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) is for the delivery of 4,566,769,113 units of Jardiance 25 mg tablets. The firm-fixed-price delivery order contract has a ceiling value of $2,382.75 and a period of performance through December 20, 2024. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, has been awarded this contract without any set-aside designation, indicating open competition. The company...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $13,135.43 firm fixed price delivery order contract for the provision of Jardiance 10 mg tablets. This order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of a pharmaceutical product, specifically Jardiance 10 mg tablets. The contract, valued at $10,932.33, was awarded on July 19, 2022 by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense (DoD). This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support...
This contract was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $21,953.06, is a Delivery Order for the supply of Jardiance 25 mg tablets. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a wide...
This is a federal contract award for $10,153.71 to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) for the delivery of Jardiance 25 mg tablets. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of August 13, 2024. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous federal contracts to supply a wide range of prescription drugs, medical supplies, and equipment to support various...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides for the delivery of Jardiance 25 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The $4,424.52 firm fixed price delivery order has a period of performance through July 2024 and is not designated as a set-aside contract. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support to supply a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a delivery order with a firm fixed price of $6,441.30 for the supply of the pharmaceutical product Jardiance 10 mg tablet. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, for a period ending on April 11, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $1,228.32 firm-fixed-price delivery order is for the supply of 4564618236 Jardiance 10 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a broad range of pharmaceutical products and medical supplies to the Department of...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of the medication Jardiance 10 mg tablets. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a ceiling value of $4,343.92. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical to provide a comprehensive range of...
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB24FL9UM
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Jardiance 25 mg tablets to the Defense Logistics Agency (DLA). The $20,056.49 fixed-price delivery order was issued under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total potential value of up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. As a major pharmaceutical distribution company, Amerisourcebergen leverages its extensive supply chain to efficiently fulfill federal government contracts for critical medical commodities.

Generated 8/25/24, 12:33 AM